3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hepatoblastoma
2
Glioblastoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Ototoxicity
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cytarabine
3
Injections
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Decitabine
2
veliparib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Temozolomide
1
Peripheral Blood Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Daunorubicin
1
CPX-351
1
Busulfan
1
Bone Marrow Transplantation
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Acute
×
Vorinostat
×
1 year
×
Clear all
No trials found.